rs17224360

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000251.3(MSH2):​c.1077-10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 1,597,360 control chromosomes in the GnomAD database, including 328 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.014 ( 23 hom., cov: 32)
Exomes 𝑓: 0.018 ( 305 hom. )

Consequence

MSH2
NM_000251.3 intron

Scores

2
Splicing: ADA: 0.3600
2

Clinical Significance

Benign reviewed by expert panel B:26

Conservation

PhyloP100: 1.78

Publications

12 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.2).
BP6
Variant 2-47429732-T-C is Benign according to our data. Variant chr2-47429732-T-C is described in ClinVar as Benign. ClinVar VariationId is 36562.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0142 (2157/152306) while in subpopulation AMR AF = 0.0295 (451/15286). AF 95% confidence interval is 0.0273. There are 23 homozygotes in GnomAd4. There are 980 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.1077-10T>C
intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.1077-10T>C
intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.1077-10T>C
intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.1077-10T>C
intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.1077-10T>C
intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.1128-10T>C
intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2157
AN:
152188
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00413
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0295
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0196
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0145
AC:
3588
AN:
247944
AF XY:
0.0145
show subpopulations
Gnomad AFR exome
AF:
0.00306
Gnomad AMR exome
AF:
0.0191
Gnomad ASJ exome
AF:
0.0377
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00180
Gnomad NFE exome
AF:
0.0195
Gnomad OTH exome
AF:
0.0235
GnomAD4 exome
AF:
0.0181
AC:
26086
AN:
1445054
Hom.:
305
Cov.:
30
AF XY:
0.0179
AC XY:
12905
AN XY:
719814
show subpopulations
African (AFR)
AF:
0.00363
AC:
120
AN:
33050
American (AMR)
AF:
0.0197
AC:
879
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.0391
AC:
1018
AN:
26032
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39542
South Asian (SAS)
AF:
0.00431
AC:
367
AN:
85246
European-Finnish (FIN)
AF:
0.00268
AC:
143
AN:
53330
Middle Eastern (MID)
AF:
0.0147
AC:
84
AN:
5730
European-Non Finnish (NFE)
AF:
0.0203
AC:
22310
AN:
1097814
Other (OTH)
AF:
0.0195
AC:
1164
AN:
59754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1278
2556
3833
5111
6389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2157
AN:
152306
Hom.:
23
Cov.:
32
AF XY:
0.0132
AC XY:
980
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00411
AC:
171
AN:
41572
American (AMR)
AF:
0.0295
AC:
451
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4830
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0196
AC:
1333
AN:
68034
Other (OTH)
AF:
0.0237
AC:
50
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
102
204
305
407
509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0182
Hom.:
33
Bravo
AF:
0.0164
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
6
Lynch syndrome 1 (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
Lynch syndrome (3)
-
-
3
not provided (3)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Benign
0.93
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.36
dbscSNV1_RF
Benign
0.50
Splicevardb
1.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17224360; hg19: chr2-47656871; API